- Home
- STAA vs HURN Comparison
STAA vs HURN Comparison
Compare STAA & HURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STAA
- HURN
- Stock Information
- Founded
- STAA 1982
- HURN 2002
- Country
- STAA United States
- HURN United States
- Employees
- STAA N/A
- HURN N/A
- Industry
- STAA Ophthalmic Goods
- HURN Professional Services
- Sector
- STAA Health Care
- HURN Consumer Discretionary
- Exchange
- STAA Nasdaq
- HURN Nasdaq
- Market Cap
- STAA 2.0B
- HURN N/A
- IPO Year
- STAA N/A
- HURN 2004
- Fundamental
- Price
- STAA $30.20
- HURN $115.91
- Analyst Decision
- STAA Buy
- HURN Strong Buy
- Analyst Count
- STAA 7
- HURN 4
- Target Price
- STAA $45.00
- HURN $131.75
- AVG Volume (30 Days)
- STAA 605.4K
- HURN 66.1K
- Earning Date
- STAA 10-30-2024
- HURN 10-29-2024
- Dividend Yield
- STAA N/A
- HURN N/A
- EPS Growth
- STAA N/A
- HURN 14.29
- EPS
- STAA 0.33
- HURN 4.16
- Revenue
- STAA $332,942,000.00
- HURN $1,425,021,000.00
- Revenue This Year
- STAA $8.76
- HURN $11.16
- Revenue Next Year
- STAA $14.28
- HURN $8.65
- P/E Ratio
- STAA $91.84
- HURN $25.27
- Revenue Growth
- STAA 8.83
- HURN 12.76
- 52 Week Low
- STAA $26.66
- HURN $84.26
- 52 Week High
- STAA $52.68
- HURN $115.65
- Technical
- Relative Strength Index (RSI)
- STAA 41.25
- HURN 66.87
- Support Level
- STAA $29.91
- HURN $103.24
- Resistance Level
- STAA $31.41
- HURN $108.75
- Average True Range (ATR)
- STAA 1.07
- HURN 2.06
- MACD
- STAA -0.08
- HURN 0.22
- Stochastic Oscillator
- STAA 15.56
- HURN 100.00
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.